scholarly article | Q13442814 |
P356 | DOI | 10.1111/TMI.12716 |
P698 | PubMed publication ID | 27125333 |
P50 | author | Landon Myer | Q60557491 |
Elaine J Abrams | Q90796636 | ||
P2093 | author name string | Kelly Nguyen | |
Stanzi M le Roux | |||
P2860 | cites work | Height, weight, and growth in children born to mothers with HIV-1 infection in Europe | Q47173963 |
Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia | Q47602881 | ||
Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding. | Q50634718 | ||
Sociodemographic characteristics, care, feeding practices, and growth of cohorts of children born to HIV-1 seropositive and seronegative mothers in Nairobi, Kenya | Q64130134 | ||
Pendulum Swings in HIV-1 and Infant Feeding Policies: Now Halfway Back | Q83756632 | ||
High Incidence of Invasive Group B Streptococcal Infections in HIV-Exposed Uninfected Infants | Q84791566 | ||
Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants | Q84819981 | ||
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q26782024 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
Exclusive breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV uninfected mothers: an intervention cohort study in KwaZulu Natal, South Africa | Q28535608 | ||
Specific antibodies against vaccine-preventable infections: a mother-infant cohort study | Q28706294 | ||
Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study | Q28744042 | ||
A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints | Q29614902 | ||
Maternal and child undernutrition and overweight in low-income and middle-income countries | Q29617926 | ||
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 | Q29620061 | ||
Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial | Q33288951 | ||
Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes | Q33572219 | ||
Bystander effects: children who escape infection but not harm | Q33579832 | ||
Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants | Q33747993 | ||
Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive | Q33865236 | ||
HIV-exposed infants: rethinking care for a lifelong condition | Q33871174 | ||
Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. | Q33872160 | ||
Breastfeeding and the risk for diarrhea morbidity and mortality | Q33875682 | ||
Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV | Q34005836 | ||
Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants | Q34163997 | ||
Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Stu | Q34305906 | ||
Neurodevelopment in Children Born to HIV-Infected Mothers by Infection and Treatment Status | Q34309494 | ||
Breastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children | Q46882840 | ||
Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? | Q34313201 | ||
Reflections on global policy documents and the WHO's infant feeding guidelines: lessons learnt | Q34331317 | ||
Evidence-based interventions for improvement of maternal and child nutrition: What can be done and at what cost? | Q34349380 | ||
Mortality and Health Outcomes of HIV-Exposed and Unexposed Children in a PMTCT Cohort in Malawi | Q34452064 | ||
Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia | Q34754843 | ||
Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration | Q35003365 | ||
Impact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in Mozambique | Q35059981 | ||
Realities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe | Q35101274 | ||
Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis | Q35101701 | ||
Impaired humoral response to vaccines among HIV-exposed uninfected infants | Q35191100 | ||
Preventing mother-to-child HIV transmission in the new millennium: the challenge of breast feeding | Q35635838 | ||
Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: follow-up of two cohorts studied in infancy | Q35655104 | ||
Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in Zambia | Q35672554 | ||
Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country | Q35748668 | ||
Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level | Q35761561 | ||
The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study | Q35914418 | ||
Treating HIV-Infected Mothers Reduces under 5 Years of Age Mortality Rates to Levels Seen in Children of HIV-Uninfected Mothers in Rural South Africa | Q36193376 | ||
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission | Q36231035 | ||
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results | Q36246590 | ||
Exclusive breastfeeding reduces risk of mortality in infants up to 6 mo of age born to HIV-positive Tanzanian women | Q36317084 | ||
Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models | Q36440580 | ||
Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. | Q36504806 | ||
HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life | Q36727938 | ||
Effects of early, abrupt weaning on HIV-free survival of children in Zambia | Q36960424 | ||
Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, Uganda | Q37068923 | ||
Paediatric HIV and neurodevelopment in sub-Saharan Africa: a systematic review | Q37126779 | ||
Reasons or excuses for avoiding meta-analysis in forest plots | Q37195565 | ||
The health of HIV‐exposed children after early weaning | Q37207636 | ||
Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia | Q37258413 | ||
Alma-Ata: Rebirth and Revision 6 Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make? | Q37268131 | ||
Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania | Q37336328 | ||
Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy | Q37365617 | ||
The HIV-exposed, uninfected African child | Q37378079 | ||
Patterns of postnatal growth in HIV-infected and HIV-exposed children | Q37407612 | ||
Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review | Q37411773 | ||
Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo | Q37456754 | ||
Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*. | Q37457004 | ||
HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana | Q37703445 | ||
Progress and barriers for the control of diarrhoeal disease | Q37770722 | ||
Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children | Q37878232 | ||
Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child | Q38112591 | ||
HIV-exposed uninfected children: a growing population with a vulnerable immune system? | Q38170189 | ||
Evidence of impact: health, psychological and social effects of adult HIV on children | Q38225902 | ||
Infections in HIV-exposed uninfected children with focus on sub-Saharan Africa | Q38237157 | ||
Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana | Q38396143 | ||
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study | Q38404645 | ||
Breastfeeding and intelligence: a systematic review and meta-analysis | Q38554479 | ||
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study | Q38876606 | ||
Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda | Q38879544 | ||
Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children | Q38879795 | ||
Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection | Q38887758 | ||
A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children | Q38913504 | ||
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis | Q39119101 | ||
Impact of HIV exposure on health outcomes in HIV-negative infants born to HIV-positive mothers in Sub-Saharan Africa. | Q39266902 | ||
Mortality among HIV-exposed infants: the first and final frontier | Q39451925 | ||
Diarrhea in children less than two years of age with known HIV status in Kisumu, Kenya | Q39550135 | ||
Inequality in early childhood: risk and protective factors for early child development | Q39570083 | ||
Neurodevelopmental impairment among infants born to mothers infected with human immunodeficiency virus and uninfected mothers from three peri-urban primary care clinics in Harare, Zimbabwe | Q40003689 | ||
Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. | Q40627787 | ||
HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants | Q42241653 | ||
Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi | Q43257966 | ||
Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy | Q43542964 | ||
Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. | Q43622760 | ||
Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo | Q44177667 | ||
Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study | Q45234931 | ||
Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group | Q45746506 | ||
Provision of micronutrient-fortified food from 6 months of age does not permit HIV-exposed uninfected Zambian children to catch up in growth to HIV-unexposed children: a randomized controlled trial | Q46183959 | ||
Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants | Q46328518 | ||
Survival of infants in the context of prevention of mother to child HIV transmission in South Africa | Q46332003 | ||
Child mortality according to maternal and infant HIV status in Zimbabwe | Q46339318 | ||
Maternal HIV-1 and HIV-2 infection and child survival in The Gambia. | Q46355172 | ||
A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants | Q46394388 | ||
HIV-positive poor women may stop breast-feeding early to protect their infants from HIV infection although available replacement diets are grossly inadequate | Q46809837 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Sub-Saharan Africa | Q132959 |
maternal health | Q6786626 | ||
P304 | page(s) | 829-45 | |
P577 | publication date | 2016-07-01 | |
P1433 | published in | Tropical Medicine and International Health | Q15765747 |
P1476 | title | Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa | |
P478 | volume | 21 |
Q47599013 | Cohort Profile: The Siyakhula Cohort, rural South Africa |
Q42362274 | Community-acquired pneumonia in children - a changing spectrum of disease |
Q58552832 | Considerations in evaluating infectious morbidity and mortality in HIV-exposed uninfected infants |
Q65001956 | Growth of HIV-Exposed Infants in Southwest China: A Comparative Study. |
Q33867971 | Growth pattern in Ethiopian infants - the impact of exposure to maternal HIV infection in relation to socio-economic factors |
Q63677375 | Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study |
Q63677376 | HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study |
Q92613507 | HIV, children, and obesity: too soon for conclusions? |
Q56998910 | Highlights from the 9 International Workshop on Pediatrics 21-22 July 2017, Paris France |
Q92607535 | Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study |
Q57471714 | Population-level Mortality Associated with HIV Exposure in HIV-uninfected Infants in Botswana and South Africa: A Model-based Evaluation |
Q91045218 | Short-term outcomes of HIV-exposed and HIV-unexposed preterm, very low birthweight neonates: a longitudinal, hospital-based study |
Q46679825 | South Africa ushers in a new era for HIV. |
Q55101336 | Surviving and Thriving-Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop. |
Search more.